53% of Indian TB patients face catastrophic costs due to delays in diagnosis, causing significant economic burden.
A new study by researchers from India, Nagpur, and the UK reveals that TB patients in India face significant economic burdens, with 53% facing catastrophic costs before starting treatment due to delays in diagnosis. The study recommends urgent actions such as intensifying private sector engagement, improving rapid diagnosis, expanding community awareness, and reimbursing pre-treatment expenses through health insurance to alleviate the burden on patients and the nation.
June 11, 2024
4 Articles